BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3901485)

  • 1. Pathology of superficial bladder cancer with emphasis on carcinoma in situ.
    Weinstein RS; Coon JS; Schwartz D; Miller AW; Pauli BU
    Urology; 1985 Oct; 26(4 Suppl):2-10. PubMed ID: 3901485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of epithelial tumors & carcinoma in situ of bladder.
    Mostofi FK; Sesterhenn IA
    Prog Clin Biol Res; 1984; 162A():55-74. PubMed ID: 6091153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologic and histologic features of superficial bladder cancer.
    Ro JY; Staerkel GA; Ayala AG
    Urol Clin North Am; 1992 Aug; 19(3):435-53. PubMed ID: 1636229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 9. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
    Josephson DY; Pasin E; Stein JP
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathology of human bladder cancer.
    Friedell GH; Parija GC; Nagy GK; Soto EA
    Cancer; 1980 Apr; 45(7 Suppl):1823-31. PubMed ID: 7370933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Microscopic classification of bladder tumors].
    Billerey C
    J Urol (Paris); 1985; 91(6):350-4. PubMed ID: 4093614
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder cancer, pathological classification and staging.
    Tavora F; Epstein JI
    BJU Int; 2008 Nov; 102(9 Pt B):1216-20. PubMed ID: 19035884
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
    Cardillo MR; Castagna G; Memeo L; De Bernardinis E; Di Silverio F
    J Exp Clin Cancer Res; 2000 Jun; 19(2):225-33. PubMed ID: 10965823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.